{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:21:35Z","timestamp":1784557295886,"version":"3.55.0"},"reference-count":8,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    <jats:bold>Background<\/jats:bold>\n                    : Aicardi-Gouti\u00e8res syndrome (AGS) is a neurogenetic leukoencephalopathy that typically manifests within the first 6\u2009months of life. Classically, AGS presents with an early encephalopathic episode characterised by feeding difficulties, irritability and psychomotor regression or delay. Cutaneous lesions affecting the extremities and epilepsy are common, with symptoms usually evolving over weeks to months before stabilising. Milder phenotypes have been described, often demonstrating relative preservation of language and cognitive function.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Case presentation<\/jats:bold>\n                    : Here, we report a case of a 31-year-old woman with compound heterozygous variants in the\n                    <jats:italic>ADAR<\/jats:italic>\n                    gene: (GRCh38) NM_001111.4:c.577C&gt;G\u2009p.(Pro193Ala) and (GRCh38) NM_001111.4:c.1111_1112del p.(Ser371Cysfs*3), consistent with AGS. The developmental history revealed normal early motor milestones. At age 3, she developed progressive ataxia and hypotonia. Over time, she exhibited spasticity, dystonia and learning difficulties, along with significant cardiac valvular calcification.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions<\/jats:bold>\n                    : The patient was recently referred for consideration of treatment with baricitinib, a selective JAK1\/JAK2 inhibitor. This case underscores the importance of considering AGS in individuals with non-classical presentations, particularly when extracerebral calcification is a notable feature.\n                  <\/jats:p>","DOI":"10.1136\/bmjno-2025-001407","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:00:22Z","timestamp":1784556022000},"page":"e001407","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Case of Aicardi-Gouti\u00e8res syndrome diagnosed in adulthood on whole-genome sequencing"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6860-0499","authenticated-orcid":false,"given":"Lewis","family":"Cobb","sequence":"first","affiliation":[{"name":"Department of Neurology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Una-Marie","family":"Sheerin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2026072007001354000_8.2.e001407.1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imr.13413","article-title":"The prototypical interferonopathy: Aicardi-Gouti\u00e8res syndrome from bedside to bench","volume":"327","author":"Hofer","year":"2024","journal-title":"Immunol Rev"},{"key":"2026072007001354000_8.2.e001407.2","doi-asserted-by":"crossref","unstructured":"Politano D , Tonduti D , Battini R , et al . Exploring emerging JAK inhibitors in the treatment of Aicardi-Gouti\u00e8res syndrome. Expert Opin Emerg Drugs 2024;1\u201319. doi:10.1080\/14728214.2024.2445508","DOI":"10.1080\/14728214.2024.2445508"},{"key":"2026072007001354000_8.2.e001407.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002228"},{"key":"2026072007001354000_8.2.e001407.4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mdc3.12903","article-title":"Diagnosis of Aicardi-Gouti\u00e8res Syndrome in Adults: A Case Series","volume":"7","author":"Videira","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"2026072007001354000_8.2.e001407.5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s12098-023-04621-w","article-title":"Aicardi-Goutieres Syndrome Type-1 without Intracranial Calcifications","volume":"90","author":"Gowda","year":"2023","journal-title":"Indian J Pediatr"},{"key":"2026072007001354000_8.2.e001407.6","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldn049"},{"key":"2026072007001354000_8.2.e001407.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106457"},{"key":"2026072007001354000_8.2.e001407.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-022-00679-2"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:00:23Z","timestamp":1784556023000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,20]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjno-2025-001407"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001407","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}